The company has received approval from the United States Food and Drug
Administration (USFDA) for its Divalproex Sodium extended-release
tablets in the strengths of 250 mg and 500 mg, Lupin said in a
statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-to-market-its-mania-and-epilepsy-treatment-drug-in-us/articleshow/71706379.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment